HEALTHCARE
MORE NEWS
Valeant Pharmaceuticals: Bill Ackman Not Entirely Responsible for Pershing’s Losses
Pershing Square investors can take it easy on Bill Ackman after Oversight Committee's revelation on Tuesday
How Amgen may Impact Regeneron Q4 Earnings
Regeneron is expected to report a jump in sales and profit in its fourth quarter earnings
Why Gilead Sciences, Inc. Should Ramp M&A Deals Before its Too Late
A timely deal will do for Gilead’s stock what earning beats and share buybacks cannot
AstraZeneca Plunges on Weak Guidance, Intense Crestor Competition
AstraZeneca disclosed upbeat 4Q earnings, but its guidance fell short of the estimates due to intense competition from generic drug-makers
GlaxoSmithKline plc (ADR) Tops Revenue, Misses Core Earnings
GlaxoSmithKline surpassed revenue expectations for the quarter, but missed on the core earnings; gross margin fell substantially